Vanguard Capital Management
ARMP icon

Vanguard Capital Management’s Armata Pharmaceuticals ARMP Stock Holding History

Vanguard Capital Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.79M Hold
487,968
– – ﹤0.01% 3397
2026
Q2 		$3.16M Buy
487,968
+121,940
+33% +$1.12M ﹤0.01% 3273
2026
Q1 		$3.75M Buy
+366,028
New +$3.08M ﹤0.01% 3164

Other funds holding ARMP

Madison Asset Management
Madison Asset Management Madison, Wisconsin $8.05B AUM 13.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $493M AUM 21.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $6.26B AUM 6.09% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SeaCrest Wealth Management
SeaCrest Wealth Management Purchase, New York $883M AUM 33.97% 1-Year Est. Return

Vanguard Capital Management's ARMP Position: Q3 2026 in Review

Vanguard Capital Management held its Armata Pharmaceuticals (ARMP) position steady in Q3 2026 at 487,968 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #3397.

Vanguard Capital Management first reported a position in ARMP in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.75M in Q1 2026. 47 funds tracked by Wall St. Rank hold ARMP as of Q3 2026.

  • Vanguard Capital Management held 487,968 shares of Armata Pharmaceuticals worth $1.79M as of Q3 2026.
  • Vanguard Capital Management left its Armata Pharmaceuticals share count unchanged in Q3 2026.
  • Armata Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3397 holding.
  • Vanguard Capital Management first reported a position in Armata Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Armata Pharmaceuticals position peaked at $3.75M in Q1 2026.
  • 47 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.